Related Experiment Videos
PHI preferentially binds to VIP receptors in normal rat tissues
1Department of Medicine, University of Calgary, Alberta, Canada.
Peptides
|September 1, 1990
Summary
Vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) primarily bind to VIP-preferring receptors in rat brain, pituitary, liver, and uterus. Distinct PHI-preferring receptors were not identified in these tissues.
Area of Science:
- Neuroendocrinology
- Receptor pharmacology
Background:
- Vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) are homologous neuropeptides with similar biological functions.
- The precise receptor interactions and distinctions between VIP and PHI remain incompletely understood.
Purpose of the Study:
- To differentiate specific binding sites for VIP and PHI in normal rat tissues.
- To investigate whether VIP and PHI utilize common or distinct receptor mechanisms.
Main Methods:
- Utilized homologous radioligands, [Tyr(125I)10]VIP and [Tyr(125I)10]rat PHI, for binding assays.
- Examined receptor binding in membranes from rat brain, anterior pituitary, liver, and uterus.
Main Results:
- Both radioligands identified VIP-preferring receptors in rat brain, anterior pituitary, and liver membranes.
- Rat PHI exhibited less than 10% of VIP's binding potency in these tissues.
- Rat uterine membranes showed a VIP receptor with 100-fold higher affinity for VIP over PHI; no specific PHI binding was detected.
Conclusions:
- Results indicate a predominance of VIP-preferring receptors over PHI-preferring receptors in the studied rat tissues.
- This suggests VIP and PHI may not have entirely distinct receptor populations in these physiological systems.